Tudor Investment Corp’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Tudor Investment Corp’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,943	Closed	-$430K	–	3023
2023 Q2	$430K	Buy	+10,943	New	+$386K	0.01%	1796
2022 Q4	–	Sell	-37,194	Closed	-$667K	–	2979
2022 Q3	$667K	Sell	37,194 -20,923	-36%	-$275K	0.01%	1195
2022 Q2	$559K	Buy	+58,117	New	+$729K	0.01%	1220
2017 Q2	–	Sell	-33,923	Closed	-$124K	–	1452
2017 Q1	$124K	Sell	33,923 -33,100	-49%	-$140K	﹤0.01%	1285
2016 Q4	$324K	Buy	67,023 +59,929	+845%	+$1.78M	0.01%	978
2016 Q3	$327K	Sell	7,094 -3,407	-32%	-$192K	0.01%	971
2016 Q2	$536K	Sell	10,501 -795	-7%	-$39.5K	0.01%	793
2016 Q1	$477K	Buy	+11,296	New	+$576K	0.01%	971

Tudor Investment Corp's ISEE Position: Q3 2023 in Review

Tudor Investment Corp sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 10,943 shares — an estimated $430K sold.

Tudor Investment Corp first reported a position in ISEE in Q1 2016 and held it in 8 quarters. The position peaked at $667K in Q3 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Tudor Investment Corp reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Tudor Investment Corp sold 10,943 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $430K.
Tudor Investment Corp first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 8 quarters.
Tudor Investment Corp's IVERIC bio, Inc. Common Stock position peaked at $667K in Q3 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.